Scientists say they may have found a way to extend human lifespan
For decades, scientists have been trying to find a way to extend human lifespan, and while studies have shown that select lab animals can live longer by eating less, they haven't conducted these studies on humans. A century-old study on lab rats has shown that mice who eat less often outlive their fed counterparts, but it can be almost impossible for most humans to follow a permanent diet.
However, a new study by the School of Biological Sciences, University of East Anglia, claims that a combination of FDA-approved drugs that mimic the effects of dieting might be the answer to a longer life. The two drugs – Rapamycin and Metformin are known to extend the lifespan of mice as much as up to 30 per cent.
Rapamycin, which was first found in the 1970s in bacteria living on the Easter Island soil, has been traditionally used as a powerful immunosuppressant to prevent organ-transplant rejection. The drug works by disabling a particular switch which is used to inform cells when a cell has an abundance of nutrients. As for Metformin, it is a synthetic compound that is found in French Lilac or Goat's Rue, which doctors prescribe to control sugar levels in type 2 diabetes.
Since both of these drugs are used to sense the nutrient and energy levels in the human body, biologists wanted to see if the combination of these drugs could have the same effect as eating less. To know more about their effects, scientists say they examined thousands of existing studies and came across 167 studies that focused on eight vertebrate species, like fish and monkeys, which offered them a detailed insight into how these drugs affected animals.
Out of three strategies that help with longevity, eating less, taking Rapamycin and consuming Metformin, scientists say the most dependable way to increase the lifespan is to eat less, irrespective of the animal's sex. They also noted that the second most effective strategy to increase lifespan was to take Rapamycin, while Metformin had no substantial effect. However, scientists did say that the effect of Rapamycin on animals wasn't consistent, as, in some cases, studies have shown that eating less or taking Rapamycin reduced an animal's lifespan.
Another thing to note here is that most of these positive effects were on mice and rats, which have genes similar to humans but are not exactly the same. And since Rapamycin does come with some side effects, like reduced immunity, scientists are now trying to see if lower doses of the drug offer some advantages without the side effects.
According to an ongoing Rapamycin trial on humans, it was noted that lower doses of the drug might help increase the lifespan. But, as of now, the trial is still in progress and will take a few years before the results are out.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
21 minutes ago
- New Indian Express
More microplastics in glass bottles than in plastic bottles: Study
PARIS: Drinks including water, soda, beer and wine sold in glass bottles contain more microplastics than those in plastic bottles, according to a surprising study released by France's food safety agency Friday. Researchers have detected the tiny, mostly invisible pieces of plastic throughout the world, from in the air we breathe to the food we eat, as well as riddled throughout human bodies. There is still no direct evidence that this preponderance of plastic is harmful to human health, but a burgeoning field of research is aiming to measure its spread. Guillaume Duflos, research director at French food safety agency ANSES, told AFP the team sought to "investigate the quantity of microplastics in different types of drinks sold in France and examine the impact different containers can have". The researchers found an average of around 100 microplastic particles per litre in glass bottles of soft drinks, lemonade, iced tea and beer. That was five to 50 times higher than the rate detected in plastic bottles or metal cans. "We expected the opposite result," PhD student Iseline Chaib, who conducted the research, told AFP. "We then noticed that in the glass, the particles emerging from the samples were the same shape, colour and polymer composition -- so therefore the same plastic -- as the paint on the outside of the caps that seal the glass bottles," she said. The paint on the caps also had "tiny scratches, invisible to the naked eye, probably due to friction between the caps when there were stored," the agency said in a statement. This could then "release particles onto the surface of the caps", it added.
Hans India
3 hours ago
- Hans India
ZeroHarm Eyes Rs 150 Crore Milestone by FY 2025 -'26, Accelerates Global Expansion into GCC
ZeroHarm Sciences, India's pioneering clean-label nutraceutical company, is set to accelerate its global footprint with a focused expansion into the GCC markets, including the UAE and the broader Middle East. Following a remarkable 10× revenue growth over the past two years and operating at a healthy ~20% EBITDA margin, the company closed the last fiscal year with 71 crore in gross revenue with an exit ARR of 90 crores. In the current fiscal, ZeroHarm is aiming for ₹150 crore in gross revenue, driven by strong domestic and global momentum and increasing traction in the United States, which now contributes nearly 30% of its overall revenue. At the heart of ZeroHarm's global success is its patented ZeroHarm BioEnhance platform, a pharma-grade nanotechnology that encapsulates plant-based actives at the nanoscale, dramatically enhancing their bioavailability by up to 5×, ensuring faster onset, precise dosing, and residue-free delivery. This breakthrough, backed by granted patents and deep R&D, makes ZeroHarm the first Indian company to bring pharmaceutical nanotech into nutraceuticals at scale. ZeroHarm's US FDA, CE, and ISO-certified formulations are backed by government-led clinical trials, with documented claims for 15 products, setting it apart in a market rife with unverified health claims. Today, the company offers over 70 targeted, condition-specific products spanning diabetes, arthritis, PCOS, liver and kidney health, immunity, and oncology support, with over million units sold across India to date. Backed by a fully owned, nanotech-enabled manufacturing facility, ZeroHarm can produce up to ₹250 crore worth of finished goods annually, making it one of the few Indian nutraceutical brands with true end-to-end production capabilities. To support its international expansion, ZeroHarm has acquired a dedicated manufacturing and R&D facility in the United States, enhancing local supply chain efficiency, fast-tracking formulation innovation, and enabling closer clinical and regulatory collaborations in key global markets. The U.S. infrastructure also gives ZeroHarm a significant strategic edge in developed markets, where stringent compliance standards often limit entry for Indian nutraceutical brands reliant on contract manufacturing. 'The global nutraceutical market is shifting, consumers are demanding not just clean labels, but clinical credibility. At ZeroHarm, we've combined deep R&D with pharma-grade nanotechnology to raise the bar for efficacy, safety, and transparency in preventive wellness. Our entry into the GCC is a natural extension of the trust we've built in India and the U.S., and a significant step toward making evidence-backed, plant-based therapeutics accessible to global consumers,' said Sachin Darbarwar, Founder & CEO, ZeroHarm Sciences. With distribution agreements and regulatory filings already underway, the company will also launch in the UK aside from the GCC markets by Q3 2025, introducing its clinically tested product lines via pharmacies, e-commerce platforms, and integrative practitioner networks.
Hindustan Times
7 hours ago
- Hindustan Times
Artichokes, a beloved Mediterranean vegetable, are a true culinary gem
Artichokes, a beloved Mediterranean vegetable, are a true culinary gem. With tender hearts and meaty leaves, they offer a subtle, nutty flavour perfect for antipasti, dips, pasta, and gourmet salads. A staple in Italian, French, and Spanish cuisine, artichokes can be grilled, stuffed, steamed, or marinated — adding elegance and depth to even Indian dishes. Preparing and eating them may take effort, but it's a labour of love your taste buds will thank you for. Once you remove the leaves and the choke, you'll reach the prized heart — a delicious reward for your patience. Cutting artichokes can seem tricky at first, but with a little practice, it becomes much easier. Medicos and dieticians alike praise artichokes for their abundance of antioxidants, fiber, and essential nutrients. They are known to support digestive health, liver function, and heart wellness. Dr Poonam Tiwari, Head of the Department of Dietetics at RMLIMS, highlights, 'Artichoke helps to regulate cholesterol levels and, as it contains cynarine, it supports bile production. It's low in calories and high in vitamins. Artichokes are both a nutritious and delicious addition to a healthy diet. Don't overcook or fry it to retain its authentic flavours.' Due to their preference for a Mediterranean climate, artichokes aren't widely cultivated in India. However, they are occasionally grown on a small scale in cooler regions like parts of Himachal Pradesh and Uttarakhand. They can be spotted in gourmet stores, with prices reaching up to ₹4,000 per piece. Despite their limited availability, the increasing interest in global cuisines is paving the way for artichokes to become a more common sight on Indian tables. Mediterranean Artichoke & Quinoa Salad Chef Mohd Shavez Ahmad, faculty at IHM, shares his recipe for a popular salad: 'Combine cooked quinoa with chopped canned artichoke hearts, cherry tomatoes, cucumber, Kalamata olives, and fresh parsley. Toss with a light dressing made of olive oil, lemon juice, garlic, and a pinch of salt and pepper. This salad is packed with protein, fiber, and antioxidants, making it perfect for a nourishing, cool meal during hot days. It's easy to prepare and offers a delightful balance of flavours and textures.' For a refreshing summer option, Chef Shavez offers an easy raita recipe: 'Try a Chilled Artichoke & Cucumber Raita — a refreshing twist on a classic Indian side. Made using readily available canned or marinated artichoke hearts (found in gourmet stores or online), chopped cucumber, hung curd, mint, and a dash of roasted cumin powder, it's light, cooling, and perfect for hot summers. This fusion raita pairs beautifully with grilled dishes or can be enjoyed on its own as a healthy snack, blending global taste with local ease.' Artichoke & Watermelon Chaat Ranjan Thakur, Executive Chef at Fairfield Marriott, suggests a gourmet twist for summer snacking with Artichoke and Watermelon Chaat: 'Combine juicy watermelon cubes with chopped canned artichoke hearts, a sprinkle of chaat masala, lemon juice, black salt, and fresh mint. This fusion salad offers the familiar tang of Indian street-style chaat with the delicate, nutty flavour of artichokes — perfect for warm climate. It's quick to prepare, hydrating, and ideal for those looking for something tasty yet healthy and unique.'
